SS Innovations recently made history by conducting the first-ever robotic cardiac surgery in Indonesia using its cutting-edge Mantra surgical robot platform. This milestone achievement took place at the Harapan Kita National Cardiac Hospital in Jakarta, where doctors successfully performed a bilateral IMA coronary artery bypass graft and ASD repair, as well as a beating heart totally endoscopic coronary artery bypass (TECAB) procedure.
The Mantra platform, specifically the Mantra 3 version, developed by the Fort Lauderdale, Florida-based company, offers a wide range of capabilities for various medical specialties, including cardiothoracic, head and neck, gynecology, urology, and general surgery. Dr. Sudhir Srivastava, the founder, chair, and CEO of SS Innovations, personally led the TECAB procedure, showcasing the advanced technology and expertise behind the robotic surgery program.
SS Innovations views this successful launch of robotic cardiac surgery in Indonesia as the start of a new era in cardiac care for the country. The collaboration between the company and Harapan Kita’s surgical team not only highlights the potential of the Mantra platform but also emphasizes the importance of advancing surgical practices to provide patients with safer, more affordable, and less invasive treatment options.
Dr. Srivastava expressed his vision of transforming surgical practices, improving access to quality healthcare, and promoting the global adoption of cost-effective robotic surgery through initiatives like the one in Indonesia. The company’s ultimate goal is to make affordable robotic surgery accessible to patients worldwide, ultimately enhancing their quality of life and recovery outcomes.
This groundbreaking achievement with the SSi Mantra platform signifies a significant step forward in the field of medical technology and sets the stage for further advancements in robotic-assisted surgeries. SS Innovations aims to build on this success, expand its presence in key markets, and continue driving innovation to benefit patients in need of advanced surgical solutions.
As the company moves forward with its regulatory approval process in the U.S. and Europe for the Mantra 3 platform, the successful outcomes of the robotic cardiac surgeries in Indonesia serve as a testament to the potential of robotic technology in revolutionizing healthcare practices. SS Innovations’ dedication to pushing the boundaries of medical innovation and improving patient care underscores the importance of investing in cutting-edge technologies for the betterment of society.
